This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Hi-Tech Pharmacal Reports Sales Of $50.5 Million For The First Quarter Ended July 31, 2013

Hi-Tech Pharmacal Co., Inc. (NASDAQ:HITK) today reported results for the Company’s fiscal first quarter ended July 31, 2013.

  • Net sales of $50.5 million for the first quarter compared to $52.0 million for the same prior year period
  • GAAP income of $4.6 million or $0.33 per diluted share for the first quarter
  • Adjusted non-GAAP net income of $6.1 million or $0.44 per diluted share for the first quarter
     
First Quarter
  2013          

2012

Net sales $ 50,501,000 $ 52,043,000
GAAP net income $ 4,550,000 $ 6,004,000
Adjusted non-GAAP net income $ 6,071,000 $ 7,137,000
GAAP Diluted EPS $ 0.33 $ 0.44
Adjusted non-GAAP Diluted EPS $ 0.44 $ 0.53
Diluted Shares 13,751,000 13,550,000

(see Table I for reconciliation to GAAP numbers)

1 of 7

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs